10-Q: PMV Consumer Q3 2025: Shell Company Reports Continued Loss

Sentiment:

Quarterly Report


PMV Consumer Acquisition Corp., a shell company, reported a net loss of $37,249 for Q3 2025 and continues its search for a business combination in the consumer products industry.

Capital raiseThe company may need to obtain additional financing to complete a business combination.Additional financing could involve issuing additional equity securities or incurring debt.Following a business combination, if cash on hand is insufficient, additional financing may be required to meet obligations.The Sponsor, officers, or directors may loan funds to cover working capital deficiencies or transaction costs, with up to $1,500,000 of such loans convertible into warrants.

Summary

  • PMV Consumer Acquisition Corp. is a Delaware-incorporated shell company formed on March 18, 2020, with the purpose of effecting a business combination, primarily in the consumer products industry.
  • The company has not commenced any operations and does not generate operating revenues, relying solely on interest income.
  • For the three months ended September 30, 2025, the company reported a net loss of $37,249, an improvement from a net loss of $45,555 for the same period in 2024.
  • For the nine months ended September 30, 2025, the net loss was $117,917, compared to $151,294 for the nine months ended September 30, 2024.
  • Cash and cash equivalents stood at $1,081,829 as of September 30, 2025, a decrease from $1,113,786 at December 31, 2024.
  • The company's securities were voluntarily delisted from the New York Stock Exchange (NYSE) on October 21, 2022, and are now quoted on the OTC Pink market, with expected limited and sporadic trading.
  • Significant corporate actions in prior periods included multiple extensions for business combination, redemptions of Class A convertible common stock, conversion of shares by the Sponsor, and a 43.792-to-1 reverse stock split effective March 12, 2024.
  • Warrants are accounted for as derivative liabilities and are re-measured at fair value each reporting period, leading to non-cash gains or losses.

Sentiment

Score: 3

Explanation: The company is a pre-revenue shell company with ongoing losses and declining cash. While losses have narrowed, the core objective of finding a business combination remains unfulfilled, and its delisting to OTC Pink significantly limits its market appeal and liquidity. The future is highly uncertain and dependent on a successful, yet elusive, business combination.

Positives

  • Net loss for the three months ended September 30, 2025, decreased to $37,249 from $45,555 in the prior year period.
  • Net loss for the nine months ended September 30, 2025, decreased to $117,917 from $151,294 in the prior year period.
  • General and administrative expenses decreased to $45,352 for the three months ended September 30, 2025, from $50,395 in the prior year period.
  • General and administrative expenses decreased to $141,273 for the nine months ended September 30, 2025, from $148,092 in the prior year period.
  • The company maintains over $1 million in cash and cash equivalents ($1,081,829 as of September 30, 2025).

Negatives

  • The company continues to incur net losses, with $37,249 for Q3 2025 and $117,917 for the nine months ended September 30, 2025.
  • Cash and cash equivalents decreased from $1,113,786 at December 31, 2024, to $1,081,829 at September 30, 2025.
  • The company has not yet identified or completed a business combination since its inception in March 2020.
  • Securities were voluntarily delisted from the NYSE and now trade on the OTC Pink, leading to limited liquidity and potential price volatility.
  • Warrants may expire worthless as the Trust Account was terminated and funds distributed.
  • Accounts payable related party increased to $602,000 at September 30, 2025, from $512,000 at December 31, 2024.

Risks

  • Public stockholders are relying on management to locate a suitable business opportunity, with no assurance of successful negotiation or consummation.
  • Executive officers and directors allocate their time to other businesses, causing conflicts of interest in their determination of time devoted to company affairs.
  • Certain executive officers and directors are, or may become, affiliated with entities engaged in similar business activities, potentially leading to conflicts of interest in presenting business opportunities.
  • Limited resources may make the company's financial condition unattractive to potential business opportunities, hindering transaction completion.
  • The company may engage in a business opportunity with entities affiliated with its Sponsor, executive officers, or directors, raising potential conflicts of interest.
  • The company will likely only be able to complete one business opportunity, leading to sole dependence on a single business and a lack of diversification, which may negatively impact operations and profitability.
  • Warrants are accounted for as liabilities, and changes in their fair value could have a material effect on financial results.
  • The company is a recently formed entity with no operating history or revenues, providing no basis to evaluate its ability to achieve its business objective.
  • If the company elects to take advantage of controlled company standards, it would be exempt from various corporate governance requirements.
  • Intense competition from other entities for business opportunities, many with greater technical, human, and financial resources.
  • Holders of Class A common stock are not entitled to vote on any election of directors; only holders of Founder Shares have this right.
  • Holders of Class B common stock are entitled to ten (10) votes for each share, potentially exerting outsized influence on stockholder matters.
  • The company is not limited to evaluating a business opportunity in a particular industry sector, making it difficult to ascertain merits or risks of any specific opportunity.
  • Ability to assess a prospective business opportunity may be limited, potentially leading to a transaction that is not as profitable as suspected.
  • Resources could be wasted researching business opportunities that are not completed, materially adversely affecting subsequent attempts.
  • The company may reincorporate in another jurisdiction, which may result in taxes imposed on stockholders.
  • Success is totally dependent upon the efforts of key personnel, and their loss could negatively impact operations and profitability.
  • Key personnel may negotiate employment or consulting agreements in connection with a business opportunity, potentially creating conflicts of interest.
  • The company may issue notes or other debt securities, or incur substantial debt, to effect a business opportunity, adversely affecting leverage and financial condition.
  • Attempting to simultaneously effect multiple business opportunities may hinder completion and give rise to increased costs and risks.
  • The company may attempt to effect a business opportunity with a private company about which little information is available, potentially resulting in an unprofitable transaction.
  • Inability to obtain additional financing to effect a business opportunity or to fund operations and growth could compel restructuring or abandonment of a transaction.
  • The Sponsor controls a substantial interest and may exert significant influence on actions requiring a stockholder vote.
  • The terms of the warrants may be amended in a manner adverse to holders of public warrants with the approval of at least 50% of outstanding public warrants.
  • As an emerging growth company and smaller reporting company, taking advantage of certain exemptions from disclosure requirements could make securities less attractive to investors and comparisons difficult.
  • Compliance obligations under the Sarbanes-Oxley Act may make it more difficult to effect a business opportunity, require substantial resources, and increase costs.
  • Provisions in the certificate of incorporation, bylaws, and Delaware law may inhibit a takeover and entrench management.
  • The exclusive forum provision in the certificate of incorporation could limit stockholders' ability to obtain a favorable judicial forum for disputes.
  • Cyber incidents or attacks directed at the company could result in information theft, data corruption, operational disruption, and/or financial loss.
  • There may be tax consequences that may adversely affect the company, including potentially becoming a personal holding company.
  • There may be uncertain or adverse U.S. federal income tax consequences, particularly regarding cashless exercise of warrants.
  • Pursuing a business opportunity outside of the United States may face additional burdens and risks (e.g., cross-border issues, currency fluctuations, political/economic conditions).
  • Risks related to consumer and consumer-related products and services industries if a business opportunity is effected in this sector.
  • Failure to maintain effective internal control over financial reporting could have a material adverse effect on the business.
  • A new 1% U.S. federal excise tax could be imposed on the company in connection with redemptions occurring after December 31, 2022.
  • Delisting from the NYSE and limited quotation in the over-the-counter market could result in limited market quotations, reduced liquidity, potential for penny stock designation, limited news/analyst coverage, and decreased ability to issue additional securities or obtain financing.

Future Outlook

The company intends to use its current cash and cash equivalents primarily to identify and evaluate potential business opportunities, perform business due diligence, and structure, negotiate, and complete a transaction, with a focus on the consumer products industry. It does not anticipate needing to raise additional funds for current operating expenditures. However, if the estimated costs for identifying and completing a business opportunity are insufficient, or if cash on hand is inadequate following a transaction, the company may need to obtain additional financing, potentially through issuing equity securities or incurring debt.

Management Comments

  • "We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business."
  • "However, if our estimate of the costs of identifying a business opportunity, undertaking in-depth due diligence and negotiating a transaction are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to a transaction."
  • "Moreover, we may need to obtain additional financing to complete a transaction, in which case we may issue additional equity securities or incur debt in connection with such transaction."
  • "In addition, following a transaction, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations."

Industry Context

PMV Consumer Acquisition Corp. operates as a Special Purpose Acquisition Company (SPAC) in the post-IPO, pre-business combination phase. The broader SPAC market has faced increased regulatory scrutiny and challenges, including the SEC Staff Statement on warrant accounting and the introduction of a 1% U.S. federal excise tax on redemptions. The company's voluntary delisting from the NYSE to the OTC Pink market is indicative of the difficulties many SPACs encounter in completing a timely business combination, often leading to reduced investor interest and significantly lower liquidity compared to major exchange-listed entities. While the company states an intention to focus on the consumer products industry, its current 'shell company' status means it has no direct operational ties or performance within that sector.

Comparison to Industry Standards

  • As a shell company with no operations or revenue, direct financial performance comparisons to operating companies in the consumer products industry are not applicable.
  • The company's continued net losses are typical for a SPAC in the search phase, as it incurs general and administrative expenses without generating operating revenue.
  • The voluntary delisting from the NYSE to the OTC Pink market is a significant negative deviation from the typical trajectory of successful SPACs, which aim to complete a de-SPAC transaction and maintain a major exchange listing. This move implies a failure to meet listing requirements or strategic decision due to lack of a target, severely impacting liquidity and investor access.
  • The accounting treatment of warrants as derivative liabilities is consistent with current SEC guidance for SPACs, reflecting an industry-wide adjustment to financial reporting standards.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Amendment to Certificate of IncorporationReduction of authorized shares of Class A common stock from 25,000,000 to 570,000, Class B common stock from 10,000,000 to 230,000, and preferred stock from 20,000,000 to 460,000.2024-04-30Streamlines the capital structure and reduces the number of authorized but unissued shares, potentially impacting future dilution capacity.
Controlled Company StatusThe company satisfies the definition of a 'controlled company' as the Sponsor holds more than 50% of the voting power for director elections.N/AAllows the company to be exempt from certain corporate governance requirements, such as having a majority of independent directors or fully independent nominating/corporate governance and compensation committees, which could reduce independent oversight.
Exclusive Forum ProvisionThe certificate of incorporation designates the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain stockholder litigation matters.N/AMay limit stockholders' ability to choose a judicial forum for disputes, potentially discouraging certain lawsuits, though it does not waive compliance with federal securities laws.

Related Party Transactions

  • The company pays an affiliate of the Sponsor $10,000 per month for office space, utilities, and secretarial/administrative support. Fees incurred were $30,000 for the three months and $90,000 for the nine months ended September 30, 2025.
  • Administrative support fees included in accounts payable related party were $602,000 at September 30, 2025, and $512,000 at December 31, 2024.
  • The company invested $1,072,897 (September 30, 2025) and $1,083,831 (December 31, 2024) in the Gabelli U.S. Treasury Money Market Fund, an affiliated entity.
  • The Sponsor, or certain officers/directors or their affiliates, may loan funds to the company to fund working capital deficiencies or transaction costs, with up to $1,500,000 of such loans convertible into warrants.

Stakeholder Impact

  • Shareholders face significant risk due to the company's shell status, lack of a business combination, delisting from a major exchange, and the high probability of warrants expiring worthless. Voting rights are concentrated with Founder Shares, limiting influence for public shareholders.
  • Creditors, particularly the related party affiliate, are exposed to increasing accounts payable, indicating continued financial support from the Sponsor's network.
  • Employees are not directly impacted as the company has no full-time employees prior to a business combination.

Next Steps

  • Identify and evaluate potential business opportunities, focusing on the consumer products industry.
  • Perform business due diligence on prospective business opportunities.
  • Structure, negotiate, and complete a business combination.
  • Potentially pursue capital raising initiatives if needed for a transaction or post-transaction operations.

Key Dates

DateDescription
2020-03-18Company incorporated in Delaware.
2020-03-20Sponsor purchased 3,593,750 shares of Class B convertible common stock (Founder Shares) for $25,000.
2020-08-03Company effected a 1.4-for-1 forward stock split of its issued and outstanding shares of Class B convertible common stock.
2020-09-21SEC declared registration statements effective for the Initial Public Offering (IPO).
2020-09-24Consummation of the Initial Public Offering; agreement to pay an affiliate of the Sponsor $10,000 per month for administrative support commenced.
2020-11-05Underwriters' over-allotment option expired unexercised, resulting in 656,250 Founder Shares being forfeited.
2022-08-22UBS agreed to waive its entitlement to the deferred underwriting commission of $4,593,750.
2022-09-21Special meeting of stockholders approved amendments to the certificate of incorporation, including extending the business combination period to September 21, 2023.
2022-09-27Sponsor contributed 200,000 shares of Class B convertible common stock to the Trust Account for the extension; $154,874,303 was removed from the Trust Account to pay redemptions.
2022-10-17Sponsor elected to convert 3,000,000 shares of Class B convertible common stock into Class A convertible common stock.
2022-10-21Last day of trading on the NYSE; voluntary delisting became effective.
2022-10-24Company's securities commenced trading on the OTC Pink.
2022-12-14Unseparated units of the company terminated trading and were subsequently separated.
2022-12-27Completion of the redemption of outstanding Class A convertible common stock; Trust Account terminated; remaining $1,531,250 of deferred underwriting fees were forfeited.
2023-02-27Sponsor purchased 204,200 shares of Class C common stock from a holder for an aggregate purchase price of $42,000.
2023-09-29Stockholders approved various amendments to the Charter and a 43.792-to-1 reverse stock split; Sponsor elected to voluntarily convert all of its Class A convertible common stock into Class C common stock.
2023-11-01Sponsor's Class C Conversion occurred; Class C common stock was renamed Class A common stock.
2023-11-02Company filed a Second Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws with the State of Delaware.
2024-03-12The Reverse Stock Split was declared effective.
2024-04-29Board of Directors recommended, and sole shareholder approved, an amendment to reduce the number of authorized shares of Class A common stock, Class B common stock, and preferred stock.
2024-04-30Company filed the Amendment to its Second Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware.
2025-09-30End of the current reporting period for the quarterly report.
2025-11-07Date of filing of the Form 10-Q and certifications by executive officers.

Recommendation

sell

The company is a shell with no operations, has been delisted from the NYSE to the illiquid OTC Pink market, and its warrants are likely to expire worthless. While it has cash, it continues to incur losses and has not yet identified a business combination since its inception in 2020. The significant risks, lack of diversification, and limited liquidity make it a highly speculative investment with a strong likelihood of capital loss.

Keywords

SPAC, shell company, consumer products, business combination, acquisition, merger, 10-Q, SEC filing, financial report, net loss, warrants, OTC Pink, delisting, corporate governance, risk factors

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.